Global Adoptive Cell Transfer Therapy Market Research Report 2022

Global Adoptive Cell Transfer Therapy Market Research Report 2022

Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type: 2017 VS 2021 VS 2028
1.2.2 NK
1.2.3 LAK
1.2.4 DC
1.2.5 CIK
1.2.6 CTL
1.2.7 TIL
1.2.8 TCR-T
1.2.9 CAR-T
1.3 Market by Application
1.3.1 Global Adoptive Cell Transfer Therapy Market Share by Application: 2017 VS 2021 VS 2028
1.3.2 Acute Lymphocytic Leukemia
1.3.3 NHL
1.3.4 Melanoma
1.3.5 Bladder Cancer
1.3.6 Lung Cancer
1.3.7 Head and Neck Cancer
1.3.8 Multiple Myeloma
1.3.9 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Adoptive Cell Transfer Therapy Market Perspective (2017-2028)
2.2 Adoptive Cell Transfer Therapy Growth Trends by Region
2.2.1 Adoptive Cell Transfer Therapy Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Adoptive Cell Transfer Therapy Historic Market Size by Region (2017-2022)
2.2.3 Adoptive Cell Transfer Therapy Forecasted Market Size by Region (2023-2028)
2.3 Adoptive Cell Transfer Therapy Market Dynamics
2.3.1 Adoptive Cell Transfer Therapy Industry Trends
2.3.2 Adoptive Cell Transfer Therapy Market Drivers
2.3.3 Adoptive Cell Transfer Therapy Market Challenges
2.3.4 Adoptive Cell Transfer Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue
3.1.1 Global Top Adoptive Cell Transfer Therapy Players by Revenue (2017-2022)
3.1.2 Global Adoptive Cell Transfer Therapy Revenue Market Share by Players (2017-2022)
3.2 Global Adoptive Cell Transfer Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Adoptive Cell Transfer Therapy Revenue
3.4 Global Adoptive Cell Transfer Therapy Market Concentration Ratio
3.4.1 Global Adoptive Cell Transfer Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Adoptive Cell Transfer Therapy Revenue in 2021
3.5 Adoptive Cell Transfer Therapy Key Players Head office and Area Served
3.6 Key Players Adoptive Cell Transfer Therapy Product Solution and Service
3.7 Date of Enter into Adoptive Cell Transfer Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Adoptive Cell Transfer Therapy Breakdown Data by Type
4.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Type (2017-2022)
4.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2023-2028)
5 Adoptive Cell Transfer Therapy Breakdown Data by Application
5.1 Global Adoptive Cell Transfer Therapy Historic Market Size by Application (2017-2022)
5.2 Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Adoptive Cell Transfer Therapy Market Size (2017-2028)
6.2 North America Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
6.3 North America Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Adoptive Cell Transfer Therapy Market Size (2017-2028)
7.2 Europe Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
7.3 Europe Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Adoptive Cell Transfer Therapy Market Size (2017-2028)
8.2 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
8.3 Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Adoptive Cell Transfer Therapy Market Size (2017-2028)
9.2 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
9.3 Latin America Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Adoptive Cell Transfer Therapy Market Size (2017-2028)
10.2 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2017-2022)
10.3 Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2023-2028)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Novartis AG
11.1.1 Novartis AG Company Detail
11.1.2 Novartis AG Business Overview
11.1.3 Novartis AG Adoptive Cell Transfer Therapy Introduction
11.1.4 Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.1.5 Novartis AG Recent Development
11.2 Kite Pharma
11.2.1 Kite Pharma Company Detail
11.2.2 Kite Pharma Business Overview
11.2.3 Kite Pharma Adoptive Cell Transfer Therapy Introduction
11.2.4 Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.2.5 Kite Pharma Recent Development
11.3 Pfizer
11.3.1 Pfizer Company Detail
11.3.2 Pfizer Business Overview
11.3.3 Pfizer Adoptive Cell Transfer Therapy Introduction
11.3.4 Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.3.5 Pfizer Recent Development
11.4 Juno Therapeutics
11.4.1 Juno Therapeutics Company Detail
11.4.2 Juno Therapeutics Business Overview
11.4.3 Juno Therapeutics Adoptive Cell Transfer Therapy Introduction
11.4.4 Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.4.5 Juno Therapeutics Recent Development
11.5 Celgene Corporation
11.5.1 Celgene Corporation Company Detail
11.5.2 Celgene Corporation Business Overview
11.5.3 Celgene Corporation Adoptive Cell Transfer Therapy Introduction
11.5.4 Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.5.5 Celgene Corporation Recent Development
11.6 CARsgen Therapeutics
11.6.1 CARsgen Therapeutics Company Detail
11.6.2 CARsgen Therapeutics Business Overview
11.6.3 CARsgen Therapeutics Adoptive Cell Transfer Therapy Introduction
11.6.4 CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.6.5 CARsgen Therapeutics Recent Development
11.7 Sorrento Therapeutics
11.7.1 Sorrento Therapeutics Company Detail
11.7.2 Sorrento Therapeutics Business Overview
11.7.3 Sorrento Therapeutics Adoptive Cell Transfer Therapy Introduction
11.7.4 Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.7.5 Sorrento Therapeutics Recent Development
11.8 Legend Biotech
11.8.1 Legend Biotech Company Detail
11.8.2 Legend Biotech Business Overview
11.8.3 Legend Biotech Adoptive Cell Transfer Therapy Introduction
11.8.4 Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.8.5 Legend Biotech Recent Development
11.9 Atara Biotherapeutics
11.9.1 Atara Biotherapeutics Company Detail
11.9.2 Atara Biotherapeutics Business Overview
11.9.3 Atara Biotherapeutics Adoptive Cell Transfer Therapy Introduction
11.9.4 Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.9.5 Atara Biotherapeutics Recent Development
11.10 Aurora Biopharma
11.10.1 Aurora Biopharma Company Detail
11.10.2 Aurora Biopharma Business Overview
11.10.3 Aurora Biopharma Adoptive Cell Transfer Therapy Introduction
11.10.4 Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.10.5 Aurora Biopharma Recent Development
11.11 Autolus Therapeutics PLC
11.11.1 Autolus Therapeutics PLC Company Detail
11.11.2 Autolus Therapeutics PLC Business Overview
11.11.3 Autolus Therapeutics PLC Adoptive Cell Transfer Therapy Introduction
11.11.4 Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.11.5 Autolus Therapeutics PLC Recent Development
11.12 Bluebird
11.12.1 Bluebird Company Detail
11.12.2 Bluebird Business Overview
11.12.3 Bluebird Adoptive Cell Transfer Therapy Introduction
11.12.4 Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.12.5 Bluebird Recent Development
11.13 Carina Biotech
11.13.1 Carina Biotech Company Detail
11.13.2 Carina Biotech Business Overview
11.13.3 Carina Biotech Adoptive Cell Transfer Therapy Introduction
11.13.4 Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.13.5 Carina Biotech Recent Development
11.14 Athenex
11.14.1 Athenex Company Detail
11.14.2 Athenex Business Overview
11.14.3 Athenex Adoptive Cell Transfer Therapy Introduction
11.14.4 Athenex Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.14.5 Athenex Recent Development
11.15 Xiangxue Pharmaceutical (Xiangxue Precision)
11.15.1 Xiangxue Pharmaceutical (Xiangxue Precision) Company Detail
11.15.2 Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
11.15.3 Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer Therapy Introduction
11.15.4 Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.15.5 Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
11.16 Hengrui Yuanzheng
11.16.1 Hengrui Yuanzheng Company Detail
11.16.2 Hengrui Yuanzheng Business Overview
11.16.3 Hengrui Yuanzheng Adoptive Cell Transfer Therapy Introduction
11.16.4 Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.16.5 Hengrui Yuanzheng Recent Development
11.17 Eureka Therapeutics
11.17.1 Eureka Therapeutics Company Detail
11.17.2 Eureka Therapeutics Business Overview
11.17.3 Eureka Therapeutics Adoptive Cell Transfer Therapy Introduction
11.17.4 Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.17.5 Eureka Therapeutics Recent Development
11.18 WuXi Juno
11.18.1 WuXi Juno Company Detail
11.18.2 WuXi Juno Business Overview
11.18.3 WuXi Juno Adoptive Cell Transfer Therapy Introduction
11.18.4 WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.18.5 WuXi Juno Recent Development
11.19 Shenzhen Inno Immunity
11.19.1 Shenzhen Inno Immunity Company Detail
11.19.2 Shenzhen Inno Immunity Business Overview
11.19.3 Shenzhen Inno Immunity Adoptive Cell Transfer Therapy Introduction
11.19.4 Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.19.5 Shenzhen Inno Immunity Recent Development
11.20 Shenzhen Binde Bio
11.20.1 Shenzhen Binde Bio Company Detail
11.20.2 Shenzhen Binde Bio Business Overview
11.20.3 Shenzhen Binde Bio Adoptive Cell Transfer Therapy Introduction
11.20.4 Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.20.5 Shenzhen Binde Bio Recent Development
11.21 Kerui Bio
11.21.1 Kerui Bio Company Detail
11.21.2 Kerui Bio Business Overview
11.21.3 Kerui Bio Adoptive Cell Transfer Therapy Introduction
11.21.4 Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.21.5 Kerui Bio Recent Development
11.22 Adaptimmune
11.22.1 Adaptimmune Company Detail
11.22.2 Adaptimmune Business Overview
11.22.3 Adaptimmune Adoptive Cell Transfer Therapy Introduction
11.22.4 Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.22.5 Adaptimmune Recent Development
11.23 Altor Bioscience Corporation
11.23.1 Altor Bioscience Corporation Company Detail
11.23.2 Altor Bioscience Corporation Business Overview
11.23.3 Altor Bioscience Corporation Adoptive Cell Transfer Therapy Introduction
11.23.4 Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.23.5 Altor Bioscience Corporation Recent Development
11.24 Cellectis
11.24.1 Cellectis Company Detail
11.24.2 Cellectis Business Overview
11.24.3 Cellectis Adoptive Cell Transfer Therapy Introduction
11.24.4 Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.24.5 Cellectis Recent Development
11.25 Takara Bio
11.25.1 Takara Bio Company Detail
11.25.2 Takara Bio Business Overview
11.25.3 Takara Bio Adoptive Cell Transfer Therapy Introduction
11.25.4 Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.25.5 Takara Bio Recent Development
11.26 Unum Therapeutics
11.26.1 Unum Therapeutics Company Detail
11.26.2 Unum Therapeutics Business Overview
11.26.3 Unum Therapeutics Adoptive Cell Transfer Therapy Introduction
11.26.4 Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022)
11.26.5 Unum Therapeutics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
Table 1. Global Adoptive Cell Transfer Therapy Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of NK
Table 3. Key Players of LAK
Table 4. Key Players of DC
Table 5. Key Players of CIK
Table 6. Key Players of CTL
Table 7. Key Players of TIL
Table 8. Key Players of TCR-T
Table 9. Key Players of CAR-T
Table 10. Global Adoptive Cell Transfer Therapy Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 11. Global Adoptive Cell Transfer Therapy Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 12. Global Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 13. Global Adoptive Cell Transfer Therapy Market Share by Region (2017-2022)
Table 14. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 15. Global Adoptive Cell Transfer Therapy Market Share by Region (2023-2028)
Table 16. Adoptive Cell Transfer Therapy Market Trends
Table 17. Adoptive Cell Transfer Therapy Market Drivers
Table 18. Adoptive Cell Transfer Therapy Market Challenges
Table 19. Adoptive Cell Transfer Therapy Market Restraints
Table 20. Global Adoptive Cell Transfer Therapy Revenue by Players (2017-2022) & (US$ Million)
Table 21. Global Adoptive Cell Transfer Therapy Market Share by Players (2017-2022)
Table 22. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Transfer Therapy as of 2021)
Table 23. Ranking of Global Top Adoptive Cell Transfer Therapy Companies by Revenue (US$ Million) in 2021
Table 24. Global 5 Largest Players Market Share by Adoptive Cell Transfer Therapy Revenue (CR5 and HHI) & (2017-2022)
Table 25. Key Players Headquarters and Area Served
Table 26. Key Players Adoptive Cell Transfer Therapy Product Solution and Service
Table 27. Date of Enter into Adoptive Cell Transfer Therapy Market
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Adoptive Cell Transfer Therapy Market Size by Type (2017-2022) & (US$ Million)
Table 30. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2017-2022)
Table 31. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 32. Global Adoptive Cell Transfer Therapy Revenue Market Share by Type (2023-2028)
Table 33. Global Adoptive Cell Transfer Therapy Market Size by Application (2017-2022) & (US$ Million)
Table 34. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2017-2022)
Table 35. Global Adoptive Cell Transfer Therapy Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 36. Global Adoptive Cell Transfer Therapy Revenue Market Share by Application (2023-2028)
Table 37. North America Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Adoptive Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 40. Europe Adoptive Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 41. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2017-2022) & (US$ Million)
Table 42. Asia-Pacific Adoptive Cell Transfer Therapy Market Size by Region (2023-2028) & (US$ Million)
Table 43. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 44. Latin America Adoptive Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 45. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2017-2022) & (US$ Million)
Table 46. Middle East & Africa Adoptive Cell Transfer Therapy Market Size by Country (2023-2028) & (US$ Million)
Table 47. Novartis AG Company Detail
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Adoptive Cell Transfer Therapy Product
Table 50. Novartis AG Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Kite Pharma Company Detail
Table 53. Kite Pharma Business Overview
Table 54. Kite Pharma Adoptive Cell Transfer Therapy Product
Table 55. Kite Pharma Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 56. Kite Pharma Recent Development
Table 57. Pfizer Company Detail
Table 58. Pfizer Business Overview
Table 59. Pfizer Adoptive Cell Transfer Therapy Product
Table 60. Pfizer Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 61. Pfizer Recent Development
Table 62. Juno Therapeutics Company Detail
Table 63. Juno Therapeutics Business Overview
Table 64. Juno Therapeutics Adoptive Cell Transfer Therapy Product
Table 65. Juno Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 66. Juno Therapeutics Recent Development
Table 67. Celgene Corporation Company Detail
Table 68. Celgene Corporation Business Overview
Table 69. Celgene Corporation Adoptive Cell Transfer Therapy Product
Table 70. Celgene Corporation Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 71. Celgene Corporation Recent Development
Table 72. CARsgen Therapeutics Company Detail
Table 73. CARsgen Therapeutics Business Overview
Table 74. CARsgen Therapeutics Adoptive Cell Transfer Therapy Product
Table 75. CARsgen Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 76. CARsgen Therapeutics Recent Development
Table 77. Sorrento Therapeutics Company Detail
Table 78. Sorrento Therapeutics Business Overview
Table 79. Sorrento Therapeutics Adoptive Cell Transfer Therapy Product
Table 80. Sorrento Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 81. Sorrento Therapeutics Recent Development
Table 82. Legend Biotech Company Detail
Table 83. Legend Biotech Business Overview
Table 84. Legend Biotech Adoptive Cell Transfer Therapy Product
Table 85. Legend Biotech Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 86. Legend Biotech Recent Development
Table 87. Atara Biotherapeutics Company Detail
Table 88. Atara Biotherapeutics Business Overview
Table 89. Atara Biotherapeutics Adoptive Cell Transfer Therapy Product
Table 90. Atara Biotherapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 91. Atara Biotherapeutics Recent Development
Table 92. Aurora Biopharma Company Detail
Table 93. Aurora Biopharma Business Overview
Table 94. Aurora Biopharma Adoptive Cell Transfer Therapy Product
Table 95. Aurora Biopharma Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 96. Aurora Biopharma Recent Development
Table 97. Autolus Therapeutics PLC Company Detail
Table 98. Autolus Therapeutics PLC Business Overview
Table 99. Autolus Therapeutics PLC Adoptive Cell Transfer TherapyProduct
Table 100. Autolus Therapeutics PLC Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 101. Autolus Therapeutics PLC Recent Development
Table 102. Bluebird Company Detail
Table 103. Bluebird Business Overview
Table 104. Bluebird Adoptive Cell Transfer TherapyProduct
Table 105. Bluebird Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 106. Bluebird Recent Development
Table 107. Carina Biotech Company Detail
Table 108. Carina Biotech Business Overview
Table 109. Carina Biotech Adoptive Cell Transfer TherapyProduct
Table 110. Carina Biotech Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 111. Carina Biotech Recent Development
Table 112. Athenex Company Detail
Table 113. Athenex Business Overview
Table 114. Athenex Adoptive Cell Transfer TherapyProduct
Table 115. Athenex Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 116. Athenex Recent Development
Table 117. Xiangxue Pharmaceutical (Xiangxue Precision) Company Detail
Table 118. Xiangxue Pharmaceutical (Xiangxue Precision) Business Overview
Table 119. Xiangxue Pharmaceutical (Xiangxue Precision) Adoptive Cell Transfer TherapyProduct
Table 120. Xiangxue Pharmaceutical (Xiangxue Precision) Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 121. Xiangxue Pharmaceutical (Xiangxue Precision) Recent Development
Table 122. Hengrui Yuanzheng Company Detail
Table 123. Hengrui Yuanzheng Business Overview
Table 124. Hengrui Yuanzheng Adoptive Cell Transfer TherapyProduct
Table 125. Hengrui Yuanzheng Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 126. Hengrui Yuanzheng Recent Development
Table 127. Eureka Therapeutics Company Detail
Table 128. Eureka Therapeutics Business Overview
Table 129. Eureka Therapeutics Adoptive Cell Transfer TherapyProduct
Table 130. Eureka Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 131. Eureka Therapeutics Recent Development
Table 132. WuXi Juno Company Detail
Table 133. WuXi Juno Business Overview
Table 134. WuXi Juno Adoptive Cell Transfer TherapyProduct
Table 135. WuXi Juno Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 136. WuXi Juno Recent Development
Table 137. Shenzhen Inno Immunity Company Detail
Table 138. Shenzhen Inno Immunity Business Overview
Table 139. Shenzhen Inno Immunity Adoptive Cell Transfer TherapyProduct
Table 140. Shenzhen Inno Immunity Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 141. Shenzhen Inno Immunity Recent Development
Table 142. Shenzhen Binde Bio Company Detail
Table 143. Shenzhen Binde Bio Business Overview
Table 144. Shenzhen Binde Bio Adoptive Cell Transfer TherapyProduct
Table 145. Shenzhen Binde Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 146. Shenzhen Binde Bio Recent Development
Table 147. Kerui Bio Company Detail
Table 148. Kerui Bio Business Overview
Table 149. Kerui Bio Adoptive Cell Transfer TherapyProduct
Table 150. Kerui Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 151. Kerui Bio Recent Development
Table 152. Adaptimmune Company Detail
Table 153. Adaptimmune Business Overview
Table 154. Adaptimmune Adoptive Cell Transfer TherapyProduct
Table 155. Adaptimmune Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 156. Adaptimmune Recent Development
Table 157. Altor Bioscience Corporation Company Detail
Table 158. Altor Bioscience Corporation Business Overview
Table 159. Altor Bioscience Corporation Adoptive Cell Transfer TherapyProduct
Table 160. Altor Bioscience Corporation Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 161. Altor Bioscience Corporation Recent Development
Table 162. Cellectis Company Detail
Table 163. Cellectis Business Overview
Table 164. Cellectis Adoptive Cell Transfer TherapyProduct
Table 165. Cellectis Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 166. Cellectis Recent Development
Table 167. Takara Bio Company Detail
Table 168. Takara Bio Business Overview
Table 169. Takara Bio Adoptive Cell Transfer TherapyProduct
Table 170. Takara Bio Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 171. Takara Bio Recent Development
Table 172. Unum Therapeutics Company Detail
Table 173. Unum Therapeutics Business Overview
Table 174. Unum Therapeutics Adoptive Cell Transfer TherapyProduct
Table 175. Unum Therapeutics Revenue in Adoptive Cell Transfer Therapy Business (2017-2022) & (US$ Million)
Table 176. Unum Therapeutics Recent Development
Table 177. Research Programs/Design for This Report
Table 178. Key Data Information from Secondary Sources
Table 179. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Adoptive Cell Transfer Therapy Market Share by Type: 2021 VS 2028
Figure 2. NK Features
Figure 3. LAK Features
Figure 4. DC Features
Figure 5. CIK Features
Figure 6. CTL Features
Figure 7. TIL Features
Figure 8. TCR-T Features
Figure 9. CAR-T Features
Figure 10. Global Adoptive Cell Transfer Therapy Market Share by Application in 2021 & 2028
Figure 11. Acute Lymphocytic Leukemia Case Studies
Figure 12. NHL Case Studies
Figure 13. Melanoma Case Studies
Figure 14. Bladder Cancer Case Studies
Figure 15. Lung Cancer Case Studies
Figure 16. Head and Neck Cancer Case Studies
Figure 17. Multiple Myeloma Case Studies
Figure 18. Other Case Studies
Figure 19. Adoptive Cell Transfer Therapy Report Years Considered
Figure 20. Global Adoptive Cell Transfer Therapy Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 21. Global Adoptive Cell Transfer Therapy Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 22. Global Adoptive Cell Transfer Therapy Market Share by Region: 2021 VS 2028
Figure 23. Global Adoptive Cell Transfer Therapy Market Share by Players in 2021
Figure 24. Global Top Adoptive Cell Transfer Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Adoptive Cell Transfer Therapy as of 2021)
Figure 25. The Top 10 and 5 Players Market Share by Adoptive Cell Transfer Therapy Revenue in 2021
Figure 26. North America Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. North America Adoptive Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 28. United States Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Canada Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. Europe Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Europe Adoptive Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 32. Germany Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. France Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. U.K. Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Italy Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Russia Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Nordic Countries Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 38. Asia-Pacific Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Asia-Pacific Adoptive Cell Transfer Therapy Market Share by Region (2017-2028)
Figure 40. China Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Japan Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. South Korea Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Southeast Asia Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. India Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 45. Australia Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 46. Latin America Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 47. Latin America Adoptive Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 48. Mexico Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 51. Middle East & Africa Adoptive Cell Transfer Therapy Market Share by Country (2017-2028)
Figure 52. Turkey Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 53. Saudi Arabia Adoptive Cell Transfer Therapy Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 54. Novartis AG Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 55. Kite Pharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 56. Pfizer Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 57. Juno Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 58. Celgene Corporation Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 59. CARsgen Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 60. Sorrento Therapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 61. Legend Biotech Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 62. Atara Biotherapeutics Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 63. Aurora Biopharma Revenue Growth Rate in Adoptive Cell Transfer Therapy Business (2017-2022)
Figure 64. Autolus Therapeutics PLC Revenue Growth Rate i

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs